Here are six takeaways:
1. Barclays issued an “underweight” rating and a $107.00 price target on the company’s stock.
2. Stryker stock presently has a consensus rating of “hold” and a consensus price target of $102.14.
3. The company’s 50-day moving average is $104.43 and its 200-day moving average is $97.59.
4. Stryker has a 12-month low of $86.68 and a 12-month high of $109.79.
5. The stock has a market cap of $40.38 billion.
6. On April 11, Stryker Spine acquired SafeWire’s product portfolio.
More articles on devices:
St. Jude Medical launches Axium Neurostimulator System — 5 highlights
JRI Orthopaedics, RESTORATION develop 3D printed bioceramic implant — 4 highlights
Stryker Spine acquires SafeWire, builds on MIS presence — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
